Skip to content

Clinical trials

Phase 3 Lymphoma, Follicular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 3 Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20132
20141
20152
20172
20181
20201
20213
20225
20231
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting6
Completed6
Unknown status6
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Janssen Research & Development, LLC2
AstraZeneca1
BeOne Medicines1
Beijing Mabworks Biotech Co., Ltd.1
Beijing Tiantan Hospital1
Celgene1
Di Deng1
Epizyme, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular28
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Bronchiolitis Obliterans Syndrome2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms2
Recurrence2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.